Related Experiment Video
Updated: Jun 17, 2026
09:09
Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
Published on: May 2, 2019
Non-viral nanosystems for systemic siRNA delivery.
Stephanie David1, Bruno Pitard, Jean-Pierre Benoît
1INSERM U646, Université d'Angers, 49100 Angers, France.
Pharmacological Research
|December 17, 2009
Summary
Developing effective siRNA delivery systems is crucial for systemic administration. This review focuses on non-viral vectors, examining their properties to advance RNA interference therapeutics.
Area of Science:
- Biotechnology
- Nanomedicine
- Molecular Biology
Background:
- Systemic administration of small interfering ribonucleic acids (siRNA) faces significant barriers, necessitating efficient delivery systems.
- Effective siRNA delivery requires protection from degradation, stability in circulation, and mechanisms to evade clearance.
- Targeting strategies (active and passive) are essential for cellular uptake and cytoplasmic delivery of siRNA for RNA interference.
Purpose of the Study:
- To review non-viral delivery systems for siRNA that have undergone in vivo evaluation or clinical trials.
- To analyze the physicochemical properties of these delivery systems to guide the development of future siRNA therapeutics.
- To highlight the potential of advanced siRNA delivery systems as future therapeutic solutions.
Main Methods:
- Literature review of non-viral delivery systems for siRNA.
- Analysis of in vivo studies and clinical trial data.
- Focus on physicochemical properties influencing delivery efficiency and safety.
Main Results:
- Various non-viral vectors exhibit distinct physicochemical properties impacting siRNA protection, stability, and targeting.
- In vivo and clinical data provide insights into the efficacy and limitations of different delivery approaches.
- Successful siRNA delivery relies on a combination of formulation stability, stealth characteristics, and effective targeting.
Conclusions:
- Optimizing physicochemical properties of non-viral vectors is key to overcoming siRNA delivery challenges.
- Continued research into advanced delivery systems is vital for realizing the therapeutic potential of RNA interference.
- Non-viral delivery systems are progressing towards clinical application for various diseases.
Related Concept Videos
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
02:30Small interfering RNAs (siRNA)
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:29Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...